XML 38 R27.htm IDEA: XBRL DOCUMENT
v3.25.2

Basic and Diluted (Loss) Income Per Common Share | 6 Months Ended
--- | ---
Jun. 30, 2025
Earnings Per Share [Abstract] |
Basic and Diluted (Loss) Income Per Common Share | 18. Basic and Diluted (Loss) Income Per Common Share Earnings (loss) per share ("EPS") is calculated using the two-class method, which allocates earnings among common stock and participating securities to calculate EPS when an entity's capital structure includes either two or more classes of common stock or common stock and participating securities. Unvested share-based payment awards, and, previously, the Series C Preferred Stock, that contain non-forfeitable rights to dividends or dividend equivalents (whether paid or unpaid) are participating securities. As such, shares of any unvested restricted stock, and, previously, the Series C Preferred Stock, of the Company are considered participating securities; however, unvested shares of restricted stock do not participate in losses and, as such, are excluded from the computation of basic earnings (loss) per share during periods of net losses. The dilutive effect, if applicable, of stock options and their equivalents (including non-vested stock issued under share-based compensation plans), is computed using the "if-converted method" if this measurement is determined to be more dilutive than the treasury stock method in a period. The Company had no dilutive common stock equivalents during the three and six months ended June 30, 2025, and during the six months ended June 30, 2024, due to the results from continuing operations being a loss, net of tax. For the three months ended June 30, 2024, all stock options were excluded from the weighted-average number of shares used to calculate diluted loss per share as their inclusion would have been anti-dilutive. For the three months ended June 30, 2025, 288,588 of common stock equivalents from unvested restricted stock awards and unvested restricted stock units were excluded from the weighted-average number of shares used to calculate diluted loss per share as their inclusion would have been anti-dilutive. For the six months ended June 30, 2025 and 2024, 291,378 and 91,296, respectively, of common stock equivalents from unvested restricted stock awards and unvested restricted stock units were excluded from the weighted-average number of shares used to calculate diluted loss per share as their inclusion would have been anti-dilutive. Other instruments that may, in the future, if the average market price of the Company's stock exceeds the conversion prices, have a dilutive effect on EPS, but were excluded from the computations of diluted net loss per share for the three and six months ended June 30, 2025, and the six months ended June 30, 2024, and may be excluded from computations of diluted EPS in the future, are: convertible preferred stock, convertible debt, and stock options. Refer to Note 14. Share-based Compensation and Note 15. Equity and Temporary Equity for additional information on INNOVATE's equity instruments. The following table presents a reconciliation of net loss to net loss used in the basic and diluted EPS calculations (in millions, except shares and per share amounts):
|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2025 |  | 2024 |  | 2025 |  | 2024
Net (loss) income |  | $ | (21.0) |  |  | $ | 13.9 |  |  | $ | (46.8) |  |  | $ | (6.2) |
Net loss attributable to non-controlling interest and redeemable non-controlling interest |  | 1.2 |  |  | 0.5 |  |  | 2.5 |  |  | 3.2 |
Net (loss) income attributable to INNOVATE Corp. |  | (19.8) |  |  | 14.4 |  |  | (44.3) |  |  | (3.0) |
Less: Preferred dividends |  | 2.2 |  |  | 0.3 |  |  | 2.5 |  |  | 0.6 |
Net (loss) income attributable to common stockholders and participating preferred stockholders |  | $ | (22.0) |  |  | $ | 14.1 |  |  | $ | (46.8) |  |  | $ | (3.6) |
Participating shares |  |  |  |  |  |  |  |
Weighted-average common shares outstanding (1) |  | 13,146,750 |  |  | 8,920,485 |  |  | 13,130,930 |  |  | 8,392,923 |
Unvested restricted stock (1) |  | — |  |  | 112,293 |  |  | — |  |  | — |
Series C Preferred stock (1) |  | — |  |  | 3,653,063 |  |  | — |  |  | 1,905,025 |
Total |  | 13,146,750 |  |  | 12,685,841 |  |  | 13,130,930 |  |  | 10,297,948 |
Percentage of (loss) earnings allocated to: |  |  |  |  |  |  |  |
Common stock |  | 100.0 | % |  | 70.3 | % |  | 100.0 | % |  | 81.5 | %
Unvested restricted stock |  | — | % |  | 0.9 | % |  | — | % |  | — | %
Series C Preferred stock |  | — | % |  | 28.8 | % |  | — | % |  | 18.5 | %
Numerator for (loss) earnings per share: |  |  |  |  |  |  |  |
Net (loss) income attributable to common stockholders, basic and diluted |  | $ | (22.0) |  |  | $ | 9.9 |  |  | $ | (46.8) |  |  | $ | (2.9) |
Effect of assumed shares under the if-converted method for preferred stock, convertible instruments and unvested restricted stock |  | — |  |  | 4.9 |  |  | — |  |  | — |
Net (loss) income attributable to common stockholders, diluted |  | $ | (22.0) |  |  | $ | 14.8 |  |  | $ | (46.8) |  |  | $ | (2.9) |
Denominator for (loss) earnings per share: |  |  |  |  |  |  |  |
Weighted-average common shares outstanding - basic (1) |  | 13,146,750 |  |  | 8,920,485 |  |  | 13,130,930 |  |  | 8,392,923 |
Effect of assumed shares under the if-converted method for preferred stock, convertible instruments and participating unvested restricted stock (1) |  | — |  |  | 5,505,271 |  |  | — |  |  | — |
Weighted-average common shares outstanding - diluted (1) |  | 13,146,750 |  |  | 14,425,756 |  |  | 13,130,930 |  |  | 8,392,923 |
(Loss) income per share |  |  |  |  |  |  |  |
Basic (1) |  | $ | (1.67) |  |  | $ | 1.11 |  |  | $ | (3.56) |  |  | $ | (0.35) |
Diluted (1) |  | $ | (1.67) |  |  | $ | 1.03 |  |  | $ | (3.56) |  |  | $ | (0.35) |
(1) Basic and diluted income (loss) per common share and weighted-average common shares outstanding for the three and six months ended June 30, 2024, in the table above have been retroactively adjusted to reflect the 1-for-10 reverse stock split effected on August 8, 2024.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration